NCT03981471 Fall Prevention in Elderly: Mechanisms and Strategies
| NCT ID | NCT03981471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Research Center for Rehabilitation Technical Aids |
| Condition | Elderly |
| Study Type | INTERVENTIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2019-06-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 4,000 participants in total. It began in 2019-06-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In communities with over 100,000 residents, to investigate the incidence and mechanisms of fall in elderly, and strategies of fall prevention.
Eligibility Criteria
Inclusion Criteria: * community dwelling adults without medical conditions to impair walking ability Exclusion Criteria: * cognitively or physically unable to cooperate with the examiner to finish the test
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03981471 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03981471 currently recruiting?
Yes, NCT03981471 is actively recruiting participants. Contact the research team at suhonglun@nrcrta.cn for enrollment information.
Where is the NCT03981471 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China.
Who is sponsoring the NCT03981471 clinical trial?
NCT03981471 is sponsored by National Research Center for Rehabilitation Technical Aids. The trial plans to enroll 4,000 participants.